Reuters logo
BRIEF-Double Bond Pharmaceutical and N.N. Alexandrov National Cancer Centre of Belarus in agreement about clinical use of Temodex
January 10, 2017 / 2:57 PM / 8 months ago

BRIEF-Double Bond Pharmaceutical and N.N. Alexandrov National Cancer Centre of Belarus in agreement about clinical use of Temodex

Jan 10 (Reuters) - Double Bond Pharmaceutical AB :

* Cooperation with N. N. Alexandrov National Cancer Centre of Belarus has been further developed through a partnership agreement concerning a follow-up of patients with brain tumors treated in Belarus in N. N. Alexandrov National Centre, which will accelerate the process of making Temodex commercially viable worldwide

Source text: bit.ly/2j3KK70

Further company coverage:

Gdynia Newsroom

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below